AAV-delivered GRK2 inhibitors (University of Chicago/University of Wisconsin-Madison)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAAV-delivered GRK2 inhibitors (University of Chicago/University of Wisconsin-Madison)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionBeta-adrenergic receptor kinase 1 inhibitors
TargetsBeta-adrenergic receptor kinase 1
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Chicago
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of ChicagoUniversity Of Wisconsin-Madison
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A